NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

Br J Cancer · 2009 · PMC2768445 · PMID 19724275

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This is highly significant as oncogenic RAS (active in approximately 30% of all human cancers) signals partly via MEK/ERK ( Schubbert et al , 2007 ), thus further investigation of NFAT signalling in the context of oncogenic Ras/RAF is merited.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.